Article
A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection
Theranostics
(2020)
Abstract
Epstein-Barr virus (EBV) is the causative pathogen for infectious mononucleosis and many kinds of malignancies including several lymphomas such as Hodgkin's lymphoma, Burkitt's lymphoma and NK/T cell lymphoma as well as carcinomas such as nasopharyngeal carcinoma (NPC) and EBV-associated gastric carcinoma (EBV-GC). However, to date no available prophylactic vaccine was launched to the market for clinical use.
Disciplines
Publication Date
2020
DOI
10.7150/thno.42494
Publisher Statement
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation Information
Xiao Zhang, Bingchun Zhao, Mingmei Ding, Shuo Song, et al.. "A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection" Theranostics Vol. 10 Iss. 13 (2020) p. 5704 - 5718 Available at: http://works.bepress.com/claude-krummenacher/8/
Creative Commons license
This work is licensed under a Creative Commons CC_BY International License.